Posted on
Vitalize
For US Audience Only
What is the purpose of this study?
We want to understand whether the study medicine can improve the symptoms of CIDP and their impact on
daily activities. You may be able to join the study if you meet these and other criteria:
Are at least 18 years of age:
- Have been diagnosed with CIDP
- Are being treated with a stable dose of immunoglobulins that are helping your disease symptoms, but not fully.
The study lasts about 2 years and has 4 parts. he study treatment is a weekly injection. After receiving the first
dose intravenously (into a vein) at the study clinic, you will come back to the clinic a week later to receive the first
subcutaneous (under the skin) injection. During that visit you will be trained on how to inject yourself at home.
LINK COMING SOON